MASSERINI, MASSIMO ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 12.478
EU - Europa 6.646
AS - Asia 1.752
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 24
AF - Africa 18
OC - Oceania 17
Totale 20.963
Nazione #
US - Stati Uniti d'America 12.141
DE - Germania 1.447
CN - Cina 1.148
SE - Svezia 1.097
IT - Italia 1.091
IE - Irlanda 868
UA - Ucraina 661
GB - Regno Unito 417
CA - Canada 327
FI - Finlandia 215
BE - Belgio 175
IN - India 149
HK - Hong Kong 137
PL - Polonia 125
FR - Francia 115
VN - Vietnam 113
RU - Federazione Russa 105
DK - Danimarca 84
AT - Austria 83
NL - Olanda 47
SG - Singapore 43
IR - Iran 37
BG - Bulgaria 36
TR - Turchia 34
EU - Europa 23
PT - Portogallo 21
JP - Giappone 18
BR - Brasile 17
ES - Italia 16
AU - Australia 15
KR - Corea 15
CH - Svizzera 14
RO - Romania 12
IL - Israele 10
MX - Messico 9
TW - Taiwan 9
CL - Cile 7
ID - Indonesia 7
HU - Ungheria 6
MY - Malesia 5
ZA - Sudafrica 5
EG - Egitto 4
GR - Grecia 4
TH - Thailandia 4
AR - Argentina 3
IQ - Iraq 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
MU - Mauritius 3
CI - Costa d'Avorio 2
LB - Libano 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HN - Honduras 1
JO - Giordania 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
SC - Seychelles 1
YE - Yemen 1
Totale 20.963
Città #
Ann Arbor 2.237
Woodbridge 1.577
Chandler 1.058
Frankfurt am Main 895
Houston 864
Dublin 844
Fairfield 832
Jacksonville 751
Wilmington 610
Ashburn 597
Dearborn 596
Milan 503
Seattle 383
New York 308
Cambridge 293
Princeton 278
Nanjing 220
Beijing 169
Brussels 169
Lachine 127
Hong Kong 121
Shanghai 117
Kraków 114
Lawrence 110
Altamura 103
Toronto 94
Nanchang 82
Vienna 82
Helsinki 80
Hangzhou 68
Guangzhou 67
San Diego 66
Boardman 64
Ottawa 64
Dong Ket 55
Andover 51
Changsha 49
Fremont 49
Tianjin 44
Wayne 43
Philadelphia 42
Shenyang 42
Falls Church 38
Hebei 36
Jiaxing 36
Plovdiv 36
Jinan 35
Mountain View 31
Nürnberg 31
Zhengzhou 28
Auburn Hills 27
Kunming 26
Norwalk 24
Rome 24
Grafing 21
Ningbo 21
Huizen 20
Redmond 20
Pune 19
London 18
Chicago 17
Montréal 16
Hefei 15
Los Angeles 15
Edmonton 14
Taizhou 14
Lecco 13
Detroit 12
Hanover 12
San Mateo 12
Monmouth Junction 11
Washington 11
Ahmedabad 10
Amsterdam 10
Fuzhou 10
Leawood 10
Segrate 10
University Park 10
Zanjan 10
New Delhi 9
Copenhagen 8
Kiev 8
Palermo 8
Porto 8
Verona 8
Cusano Milanino 7
Duncan 7
Pavia 7
Rajsamand 7
São Paulo 7
Tappahannock 7
Central 6
Central District 6
Changchun 6
Novara 6
Pisa 6
Taipei 6
Bangalore 5
Daejeon 5
Genova 5
Totale 15.783
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 423
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 344
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 322
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 311
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 304
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 285
Morphogenic effect of common solvent in the self-assembly behavior of amphiphilic PEO-b-PLA 282
Nanomedicine for the treatment of Alzheimer's disease 271
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 268
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 256
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 246
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 241
Versatile and Efficient Targeting Using a Single Nanoparticulate Platform and its Application to Cancer and Alzheimer's Disease 233
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 229
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 222
TrkA pathway activation induced by amyloid-beta (Abeta) 218
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 218
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 216
Curcumin derivatives as new ligands of Aβ peptides 211
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 211
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 211
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 209
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 208
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 208
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 198
Effect of nanoparticles binding β-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 190
Developmental changes in the protein composition of sphingolipid- and cholesterol-enriched membrane domains of rat cerebellar granule cells 186
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 186
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 185
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 180
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 179
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 179
Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds 179
Immunoseparation of Prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells 177
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 177
Interactions of proteins with ganglioside-enriched microdomains on the membrane: the lateral phase separation of molecular species of GD1a ganglioside, having homogeneous long-chain base composition, is recognized by Vibrio cholerae sialidase 176
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 176
Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor 176
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model 174
Enhanced brain targeting of engineered solid lipid nanoparticles 174
Effect of modified collagen on amyloid beta peptide aggregation 172
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 171
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 170
Pin1: a new outlook in Alzheimer's disease 170
Role of lipid rafts and GM1 in the segregation and processing of Prion Protein 166
Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin 164
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 164
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 160
Detection and Characterization of Different Brain-Derived Subpopulations of Plasma Exosomes by Surface Plasmon Resonance Imaging 160
Abnormal cross-talk between mutant presenilin 1 (I143T, G384A) and glycosphingolipid biosynthesis 159
mApoE-Functionalized Nanoliposomes Delivering Doxorubicin and Ultrasmall Superparamagnetic Iron Oxide to Glioblastoma Cells Characterized by TEM and Confocal Microscopy 158
Pin1 affects Tau phosphorylation in response to Abeta oligomers 157
ALCOHOL AND NEURAL LIPIDS 157
Ceramides and sphingomyelinases in senile plaques 157
Enhanced brain targeting of engineered solid lipid nanoparticles 157
Two tail-anchored protein variants, differing in transmembrane domain length and intracellular sorting, interact differently with lipids 154
Age-related changes in the ceramide composition of the major gangliosides present in rat brain subcellular fractions enriched in plasma membranes of neuronal and myelin origin 154
Dependence of rat liver CMP-N-acetylneuraminate:GM1 sialyltransferase (SAT IV) activity on the ceramide composition of GM1 ganglioside 153
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 153
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 153
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 152
Role of phosphatidylethanol in membranes. Effects on membrane fluidity, tolerance to ethanol, and activity of membrane-bound enzymes 151
Thermotropic behavior of fatty acid ethyl esters in phospholipid liposomes 151
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 149
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 149
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 149
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 148
A surveillance system for early-stage diagnosis of endogenous diseases by swarms of nanobots 147
Nanotechnology for neurodegenerative disorders 147
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients 146
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 145
Palmitic is the main fatty acid carried by lipids of detergent-resistant membrane fractions from neural and non-neural cells 143
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 143
Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells 142
Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides 141
Methyl-β-cyclodextrin treatment affects the thermotropic behaviour of membranes and detergent-resistant membrane fractions of cultured A431 cells 141
Changes in the composition of detergent-resistant membrane domains of cultured neurons following protein kinase C activation 141
Early-Stage Diagnosis of Endogenous Diseases by Swarms of Nanobots: An Applicative Scenario 137
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 137
New tricyclic compounds, process for their manufacture and their use as ligands of beta-alyloid peptides 136
Effect of curcumin-associated and lipid ligand functionalised nanoliposomes on aggregation of the Alzheimer's Aβ peptide 136
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 135
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 134
Preparation and use of liposomes for the study of sphingolipid segregation in membrane model systems 133
Nanomedicine for the treatment of Alzheimer's disease 132
Nanotechnology for neurodegenerative disorders 131
Stability of Aβ (1-42) peptide fibrils as consequence of environmental modifications 129
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide 128
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 126
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 126
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 124
Glycolipid-protein interaction in the mechanism of signal transduction: studies with a photoactivable ganglioside analogue 123
Self-assembled electrical biodetector based on reduced graphene oxide 123
Implicazioni nutrizionali nella malattia di Alzheimer 122
Functionalization with curcumin-derivative and TAT peptide enhances the interaction with human brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 122
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 121
Proteomics of plasma membrane microdomains 120
Lipid domains in the membrane: thermotropic properties of sphingomyelin vesicles containing GM1 ganglioside and cholesterol 119
A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1 Delta E9 Mouse Model of Alzheimer's Disease 119
Evidence for nonrandom distribution of GD1a ganglioside in rabbit brain microsomal membranes 118
Totale 17.664
Categoria #
all - tutte 53.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.121 0 0 0 0 0 0 0 0 123 277 321 400
2019/20204.073 472 272 274 277 434 484 632 301 383 211 263 70
2020/20212.536 227 153 286 288 204 165 269 153 236 258 96 201
2021/20221.838 98 167 176 189 76 175 142 100 104 169 158 284
2022/20234.091 449 1.198 338 396 230 562 90 244 287 61 169 67
2023/20242.252 102 107 166 172 336 678 554 121 16 0 0 0
Totale 21.649